Clinical Trial

Study of the Risk of Ischaemia Following the Creation of an Arteriovenous Fistula

Study acronym: MODIFVASC
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to identify functional vascular changes and clinical factors correlated with the occurrence of short- or medium-term hand ischaemia after arteriovenous fistula creation.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-02-29; most recent amendment 2025-11-19.
Status change: Not Yet Recruiting → Recruiting 2025-11-19
Trial Details
NCT Number NCT06297343
Lead Sponsor GCS Ramsay Santé pour l'Enseignement et la Recherche
Collaborators: Euraxi Pharma
Conditions Renal Failure
Enrollment 544 participants
Start Date 2025-10-20
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-11-24